Assessment of the timing of histologic and molecular testing indicates that testing occurred prior to treatment initiation for most patients with metastatic non—small cell lung cancer.
Jack Mardekian, PhD
Advertisement
Articles by Jack Mardekian, PhD
This study identified inefficiencies in drug and medical service utilization related to pain management among Medicare members with osteoarthritis and chronic low back pain.
Advertisement
Latest Updated Articles
- Molecular Testing Patterns in Metastatic Non—Small Cell Lung Cancer
Published: February 3rd 2016 | Updated:
- Inefficiencies in Osteoarthritis and Chronic Low Back Pain Management
Published: October 23rd 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo
2
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
3
Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS
4
FDA Grants Breakthrough Therapy Designation to R-DXd in CDH6-Expressing Ovarian Cancer
5
